ANIMAL MODELS OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY
ANIMAL MODELS OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY
批准号:
6217849
负责人:
Michael Byrne Robinson
金额:
$14.69万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-16 至 2000-11-30
关键词:
Adenoviridae athymic mouse avoidance behavior defective virus disease /disorder model enzyme therapy gene expression gene therapy genetic transduction glutamine histopathology immune tolerance /unresponsiveness laboratory mouse mature animal neurochemistry newborn animals nonhuman therapy evaluation ornithine carbamoyl phosphate deficiency ornithine carbamoyltransferase orotate quinolinate serotonin transfection /expression vector urea cycle urinalysis
中文摘要
该项目的总体目标是研究体内基因的功效。
重组腺病毒对两种鸟氨酸动物模型的治疗
转氨甲基酶缺乏症(OTCD)、稀毛(SPF)小鼠和
皮肤和毛发异常(SPF/ASH)小鼠。一种有用的动物的出现
模型允许我们尝试在新生和成年动物身上进行基因治疗
使用各种重组腺病毒并检测代谢和
将被证明对人体研究有用的神经化学变化
我们的研究将围绕这些反应展开
对体内基因治疗将具有最大意义的
人体研究:(1)新陈代谢反应,特别是关于
氨转化为尿素;(2)腺病毒的安全性
给药;以及(3)神经化学/神经病理反应
基因治疗,因为最坏的后果(死亡除外)
高氨血症是脑损伤和智力低下。一共有四个
具体目标:i开发代谢和神经化学措施,以
将允许评估基因疗法的疗效;ii研究
基因表达的水平、分布和时程及其研究
纠正代谢异常,包括旋转排泄,在
体内尿素生产具有稳定的同位素和稳定的水平
氨基酸;III测试基因治疗对新生儿SPF和
SPF/ASH小鼠以确定持续时间和耐受性的存在;以及IV
以检测神经化学和行为改变是否
高氨血症引起的神经病理是可以预防的
在年长的动物身上是可逆的。
英文摘要
The overall goal of this project is to study the efficacy of in vivo gene
therapy with recombinant adenoviruses in two animal models of ornithine
transcarbamylase deficiency (OTCD), the sparse fur (Spf) mouse and the
abnormal skin and hair (Spf/ash) mouse. The presence of a useful animal
model permits us to attempt gene therapy in neonatal and adult animals
using various recombinant adenoviruses and detect metabolic and
neurochemical changes that will prove useful in the human studies
described in Project III. Our studies will revolve around those responses
to in vivo gene therapy that will be of greatest significance to the
human studies: (1) The metabolic response, particularly with regard to
the conversion of ammonia to urea; (2) The safety of adenoviral
administration; and (3) The neurochemical/neuropathologic response to
gene therapy, since the worst consequence (other than death) of
hyperammonemia is brain damage and mental retardation. There are four
specific aims: I to develop the metabolic and neurochemical measures that
will permit assessment of efficacy of gene therapy; II to study the
level, distribution, and time-course of gene expression and to study
correction of metabolic abnormalities, including orotate excretion, in
vivo urea production with stable isotopes, and steady state levels of
amino acids; III to test the efficacy of gene therapy in neonatal Spf and
Spf/ash mice to determine duration and the presence of tolerance; and IV
to detect if the neurochemical and behavioral alterations and
neuropathology induced by hyperammonemia are preventable in neonates and
reversible in older animals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10450693
-
项目类别:
-
资助金额:$23.56万
-
财政年份:2021
-
负责人:Michael Byrne Robinson
-
依托单位:
Administrative Core
-
批准号:10239999
-
项目类别:
-
资助金额:$18.91万
-
财政年份:2021
-
负责人:Michael Byrne Robinson
-
依托单位:
The Intellectual and Developmental Disabilities Research Center (IDDRC) at CHOP/Penn
-
批准号:10239998
-
项目类别:
-
资助金额:$132.38万
-
财政年份:2021
-
负责人:Michael Byrne Robinson
-
依托单位:
Administrative Core
-
批准号:10678889
-
项目类别:
-
资助金额:$23.56万
-
财政年份:2021
-
负责人:Michael Byrne Robinson
-
依托单位:
Astroglial Glutamate Transporters, Calcium, and Mitochondria
-
批准号:10189721
-
项目类别:
-
资助金额:$50.74万
-
财政年份:2018
-
负责人:Michael Byrne Robinson
-
依托单位:
Regulation of glutamate transport in astrocyte subtypes and in ALS
-
批准号:9027947
-
项目类别:
-
资助金额:$48.56万
-
财政年份:2015
-
负责人:Michael Byrne Robinson
-
依托单位:
Analytical Neurochemistry: Core D
-
批准号:9054633
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2015
-
负责人:Michael Byrne Robinson
-
依托单位:
Astroglial Glutamate Transporters, Energetics, and Mitochondria
-
批准号:8678737
-
项目类别:
-
资助金额:$36.27万
-
财政年份:2012
-
负责人:Michael Byrne Robinson
-
依托单位:
Astroglial Glutamate Transporters, Energetics, and Mitochondria
-
批准号:8520412
-
项目类别:
-
资助金额:$35.36万
-
财政年份:2012
-
负责人:Michael Byrne Robinson
-
依托单位:
Astroglial Glutamate Transporters, Calcium, and Mitochondria
-
批准号:9518087
-
项目类别:
-
资助金额:$54.61万
-
财政年份:2012
-
负责人:Michael Byrne Robinson
-
依托单位:
Astroglial Glutamate Transporters, Energetics, and Mitochondria
-
批准号:8401743
-
项目类别:
-
资助金额:$36.64万
-
财政年份:2012
-
负责人:Michael Byrne Robinson
-
依托单位:
Analytical Neurochemistry and Spectroscopy Core
-
批准号:8038873
-
项目类别:
-
资助金额:$22.74万
-
财政年份:2010
-
负责人:Michael Byrne Robinson
-
依托单位:
CORE--ANALYTIC NEUROCHEMISTRY AND SPECTROSCOPY CORE
-
批准号:7670396
-
项目类别:
-
资助金额:$25.53万
-
财政年份:2008
-
负责人:Michael Byrne Robinson
-
依托单位:
New Perspectives in Transporter Biology (FASEB Conference)
-
批准号:7000973
-
项目类别:
-
资助金额:$4.04万
-
财政年份:2005
-
负责人:Michael Byrne Robinson
-
依托单位:
Trafficking of a Neuronal Glutamate Transporter, EAAC1
-
批准号:7367901
-
项目类别:
-
资助金额:$32.76万
-
财政年份:1999
-
负责人:Michael Byrne Robinson
-
依托单位:
TRAFFICKING OF A NEURONAL GLUTAMATE TRANSPORTER, EXCITAT
-
批准号:2893319
-
项目类别:
-
资助金额:$27.76万
-
财政年份:1999
-
负责人:Michael Byrne Robinson
-
依托单位:
Trafficking of a Neuronal Glutamate Transporter, EAAC1
-
批准号:7027708
-
项目类别:
-
资助金额:$33.74万
-
财政年份:1999
-
负责人:Michael Byrne Robinson
-
依托单位:
TRAFFICKING OF A NEURONAL GLUTAMATE TRANSPORTER, EAAC1
-
批准号:6394193
-
项目类别:
-
资助金额:$29.48万
-
财政年份:1999
-
负责人:Michael Byrne Robinson
-
依托单位:
TRAFFICKING OF A NEURONAL GLUTAMATE TRANSPORTER, EAAC1
-
批准号:6188296
-
项目类别:
-
资助金额:$31.23万
-
财政年份:1999
-
负责人:Michael Byrne Robinson
-
依托单位:
Trafficking of a Neuronal Glutamate Transporter, EAAC1
-
批准号:6922596
-
项目类别:
-
资助金额:$36.97万
-
财政年份:1999
-
负责人:Michael Byrne Robinson
-
依托单位:
海外基金